This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Jim Cramer's 'Mad Money' Recap: Why Aren't Well-Run Companies Getting Respect?

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK ( TheStreet) -- The markets need to show more respect for well-run companies, Jim Cramer announced to his Mad Money viewers Thursday. Cramer said what seems overvalued on paper today might surprise you and be in a whole new category tomorrow.

Companies executing well have been a big part of the market's recent move, Cramer continued. Case in point" Costco (COST), a stock that was featured in a negative article the front page of today's Wall Street Journal, only to deliver a strong 8% rise in same-store sales hours later. Costco was not "left in the cold" as the article suggested, it was undervalued and underestimated.

Then there's Kroger (KR), our nation's second-largest grocer, which saw its share rise 7% on the day. Cramer said Kroger continues to innovate on every level, consolidating a fragmented industry, bringing down costs and boosting high-margin private label offerings. Bubble? No, value.

In the biotech space, Cramer highlighted Pharmacyclics (PCYC), which popped 10% on a takeover bid from Abbvie (ABBV), a stock which Cramer owns for his charitable trust, Action Alerts PLUS. Pharmacyclics seemed like a bubble yesterday, up 88% so far this year, but today a smart company swooped in and took it to a whole new level. Could other Cramer faves like Isis Pharmaceuticals (ISIS), Receptos (RCPT) or BioMarin (BMRN) be next?

All over the markets, companies are making smart decisions, Cramer said, like NXP Semiconductor (NXPI) making a stellar acquisition where one plus one really does equal three, or maybe even four.

Great execution can also be seen in the restaurant space. For years, Darden Restaurants (DRI) was poorly run and its stock suffered. But today, Darden is well run and its stock it on the move.

Get Defensive

It's a great time to be a defense contractor, Cramer told viewers. Just look at the results of stocks like Boeing (BA), up 33%, Lockheed Martin (LMT), up 20%, and Action Alerts PLUS holding, United Technologies (UTX), up 24%, since the markets' Ebola-induced lows in mid-October.

But while the markets clear like the big boys, Cramer said he's focused on a small, newly minted defense name, Orbital ATK (OA - Get Report), the combination of Orbital Sciences and ATK Systems, which closed just last month.

Cramer said the new company is still small, valued at $4 billion, but deserves to go much high. Orbital ATK now has its hands in everything from ammunition to advanced space and flight system technology. The new company will derive 26% of its revenue from space systems, which includes some 95 satellites currently in production and 800 already in orbit; and 42% from defense, such as small and medium caliber ammunition.

Shares of Orbital ATK currently trade at just 13 times forward earnings, a steal compared to its peers, which average 17 to 18 times earnings. Orbital ATK also sports a modest 1.9% dividend yield, but has the possibility for a dividend boost and stock buyback program once the new company gets settled. 

Must Read: Credit Suisse: 8 Must-Own Consumer Stocks for Your Portfolio

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
OA $67.75 0.00%
TRAK $40.72 0.00%
AAPL $126.41 0.00%
FB $81.21 0.00%
GOOG $575.33 0.00%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs